Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study
Open Access
- 1 April 2017
- journal article
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 2 (2) , 118-124
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Advances in Lipidomics for Cancer Biomarkers DiscoveryInternational Journal of Molecular Sciences, 2016
- Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancerOncogene, 2015
- Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal CancerBioMed Research International, 2015
- Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapyMolecular BioSystems, 2013
- hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapyInternational Journal of Colorectal Disease, 2012
- Choline metabolism in malignant transformationNature Reviews Cancer, 2011
- Biomarkers for Response to Neoadjuvant Chemoradiation for Rectal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- hPEBP4 Resists TRAIL-induced Apoptosis of Human Prostate Cancer Cells by Activating Akt and Deactivating ERK1/2 PathwaysJournal of Biological Chemistry, 2007
- Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Sensitizes Breast Cancer Cells to Tumor Necrosis Factor-α–Induced Apoptosis and Cell Growth ArrestClinical Cancer Research, 2005
- Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD.2000